BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 22815171)

  • 41. Globalization of P4 medicine: predictive, personalized, preemptive, and participatory--summary of the proceedings of the Eighth International Symposium of the International Society for Strategic Studies in Radiology, August 27-29, 2009.
    Bradley WG; Golding SG; Herold CJ; Hricak H; Krestin GP; Lewin JS; Miller JC; Ringertz HG; Thrall JH
    Radiology; 2011 Feb; 258(2):571-82. PubMed ID: 21273521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. From systems biology to P4 medicine: applications in respiratory medicine.
    Noell G; Faner R; Agustí A
    Eur Respir Rev; 2018 Mar; 27(147):. PubMed ID: 29436404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systems pharmacology meets predictive, preventive, personalized and participatory medicine.
    Jenkins SL; Ma'ayan A
    Pharmacogenomics; 2013 Jan; 14(2):119-22. PubMed ID: 23327571
    [No Abstract]   [Full Text] [Related]  

  • 44. Precision Medicine and the Changing Landscape of Research Ethics.
    Hammer MJ
    Oncol Nurs Forum; 2016 Mar; 43(2):149-50. PubMed ID: 26906126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of genetic dynamics and single-cell heterogeneity on development of nonstandard personalized medicine strategies for cancer.
    Beckman RA; Schemmann GS; Yeang CH
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14586-91. PubMed ID: 22891318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. P4 medicine: the future around the corner.
    Sobradillo P; Pozo F; Agustí A
    Arch Bronconeumol; 2011 Jan; 47(1):35-40. PubMed ID: 21190770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacomicrobiomics-Guided Precision Oncology: A New Frontier of P4 (Predictive, Personalized, Preventive, and Participatory) Medicine and Microbiome-Based Therapeutics.
    Arga KY; Attia H; Aziz RK
    OMICS; 2024 Jan; 28(1):5-7. PubMed ID: 38190279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Application of P4 (Predictive, Preventive, Personalized, Participatory) Approach to Occupational Medicine.
    Boffetta P; Collatuzzo G
    Med Lav; 2022 Feb; 113(1):e2022009. PubMed ID: 35226650
    [TBL] [Abstract][Full Text] [Related]  

  • 49. P4 medicine: how systems medicine will transform the healthcare sector and society.
    Flores M; Glusman G; Brogaard K; Price ND; Hood L
    Per Med; 2013; 10(6):565-576. PubMed ID: 25342952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive, Personalized, Preventive and Participatory (4P) Medicine Applied to Telemedicine and eHealth in the Literature.
    Alonso SG; de la Torre Díez I; Zapiraín BG
    J Med Syst; 2019 Apr; 43(5):140. PubMed ID: 30976942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Genomics and personalized medicine].
    Mooser V
    Praxis (Bern 1994); 2014 May; 103(10):567-71. PubMed ID: 24800768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systems pharmacology of complex diseases.
    Hansen J; Zhao S; Iyengar R
    Ann N Y Acad Sci; 2011 Dec; 1245():E1-5. PubMed ID: 22417173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. From -omics to personalized medicine in nephrology: integration is the key.
    Pesce F; Pathan S; Schena FP
    Nephrol Dial Transplant; 2013 Jan; 28(1):24-8. PubMed ID: 23229923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008).
    Aebersold R; Auffray C; Baney E; Barillot E; Brazma A; Brett C; Brunak S; Butte A; Califano A; Celis J; Cufer T; Ferrell J; Galas D; Gallahan D; Gatenby R; Goldbeter A; Hace N; Henney A; Hood L; Iyengar R; Jackson V; Kallioniemi O; Klingmüller U; Kolar P; Kolch W; Kyriakopoulou C; Laplace F; Lehrach H; Marcus F; Matrisian L; Nolan G; Pelkmans L; Potti A; Sander C; Seljak M; Singer D; Sorger P; Stunnenberg H; Superti-Furga G; Uhlen M; Vidal M; Weinstein J; Wigle D; Williams M; Wolkenhauer O; Zhivotovsky B; Zinovyev A; Zupan B
    Mol Oncol; 2009 Feb; 3(1):9-17. PubMed ID: 19383362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Precision Medicine, Cardiovascular Disease and Hunting Elephants.
    Joyner MJ
    Prog Cardiovasc Dis; 2016; 58(6):651-60. PubMed ID: 26902518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Taking Systems Medicine to Heart.
    Trachana K; Bargaje R; Glusman G; Price ND; Huang S; Hood LE
    Circ Res; 2018 Apr; 122(9):1276-1289. PubMed ID: 29700072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetics and genomics: the scientific drivers of personalized medicine.
    Kurnat-Thoma EL
    Annu Rev Nurs Res; 2011; 29():27-54. PubMed ID: 22891497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "
    Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Problems, challenges and promises: perspectives on precision medicine.
    Duffy DJ
    Brief Bioinform; 2016 May; 17(3):494-504. PubMed ID: 26249224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease.
    Strianese O; Rizzo F; Ciccarelli M; Galasso G; D'Agostino Y; Salvati A; Del Giudice C; Tesorio P; Rusciano MR
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32640513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.